Alix School of Medicine, Mayo Clinic, Scottsdale, Arizona.
Department of Emergency Medicine, Mayo Clinic, Phoenix, Arizona.
J Emerg Med. 2023 Apr;64(4):471-475. doi: 10.1016/j.jemermed.2023.01.008. Epub 2023 Mar 28.
Research suggests that opioid treatment for abdominal pain, which comprises a large proportion of patients presenting to the emergency department (ED), may contribute to long-term opioid use without significant benefits with regard to symptom management.
This study seeks to assess the association between opioid use for management of abdominal pain in the ED and return ED visits for abdominal pain within 30 days for patients discharged from the ED at initial presentation.
We conducted a retrospective, multicenter observational study of adult patients presenting to and discharged from 21 EDs with a chief concern of abdominal pain between November 2018 and April 2020. The proportion of 30-day return visits to the ED for patients who received opioid analgesics was compared with a reference group of patients who only received acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), or both.
Of the 4745 patients, 1304 (27.5%) received opioids and 1101 (23.2%) only received either acetaminophen, NSAIDs, or both. Among those given opioids, 287 (22.0%) returned to the ED for abdominal pain within 30 days, compared with 162 (14.7%) of those in the reference group (odds ratio 1.57, 95% confidence interval 1.27-1.95, p-value < 0.001).
Patients given opioids for abdominal pain in the ED had 57% increased odds of a return ED visit within 30 days compared with those given only acetaminophen or NSAIDs. This warrants further research on the use of nonopioid analgesics in the ED, especially in patients with anticipated discharge.
研究表明,在急诊科(ED)就诊的大量腹痛患者接受阿片类药物治疗,虽然在症状管理方面没有显著获益,但可能导致长期使用阿片类药物。
本研究旨在评估 ED 中腹痛管理中使用阿片类药物与初始就诊后 30 天内因腹痛返回 ED 的就诊之间的关联。
我们进行了一项回顾性、多中心观察性研究,纳入 2018 年 11 月至 2020 年 4 月期间因腹痛为主诉就诊并从 21 家 ED 出院的成年患者。比较接受阿片类镇痛药的患者与仅接受对乙酰氨基酚、非甾体抗炎药(NSAIDs)或两者联合治疗的患者 30 天内返回 ED 的就诊比例。
在 4745 例患者中,1304 例(27.5%)接受了阿片类药物治疗,1101 例(23.2%)仅接受了对乙酰氨基酚、NSAIDs 或两者联合治疗。在接受阿片类药物治疗的患者中,287 例(22.0%)在 30 天内因腹痛返回 ED,而在参照组中为 162 例(14.7%)(比值比 1.57,95%置信区间 1.27-1.95,p 值 < 0.001)。
与仅接受对乙酰氨基酚或 NSAIDs 治疗的患者相比,ED 中因腹痛给予阿片类药物的患者在 30 天内返回 ED 的就诊可能性增加 57%。这需要进一步研究 ED 中非阿片类镇痛药的使用,特别是在预计出院的患者中。